sanofi-aventis

1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 535 432
Medical Information e-mail: uk-medicalinformation@sanofi-aventis.com

Patient Information Leaflet last updated on the eMC: 22/12/2011
PIL Stemetil Injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 22/12/2011 and displayed until Current
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
Updated on 27/07/2010 and displayed until 22/12/2011
Reasons for adding or updating:
  • Change to storage instructions
Updated on 21/04/2010 and displayed until 27/07/2010
Reasons for adding or updating:
  • Change of trade or generic name
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 04/12/2008 and displayed until 21/04/2010
Reasons for adding or updating:
  • Change to name of manufacturer
Updated on 11/07/2008 and displayed until 04/12/2008
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 20/11/2006 and displayed until 11/07/2008
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   prochlorperazine mesilate